Lifeon Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 90.2271 million yuan, an increase of 16.53%
According to the Zhitong Finance APP, Lifeon Pharmaceutical released its semi-annual report for 2025, with operating revenue of 732 million yuan, a year-on-year decrease of 4.80%. The net profit attributable to shareholders of the listed company was 90.2271 million yuan, a year-on-year increase of 16.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.2209 million yuan, a year-on-year decrease of 9.68%. The basic earnings per share were 0.47 yuan
According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) released its semi-annual report for 2025, showing an operating income of 732 million yuan, a year-on-year decrease of 4.80%. The net profit attributable to shareholders of the listed company was 90.2271 million yuan, a year-on-year increase of 16.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.2209 million yuan, a year-on-year decrease of 9.68%. The basic earnings per share were 0.47 yuan
